These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Dolcetti R Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317 [TBL] [Abstract][Full Text] [Related]
9. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders. Swinnen LJ Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187 [TBL] [Abstract][Full Text] [Related]
10. Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease. Allen U; Hebert D; Petric M; Tellier R; Tran D; Superina R; Stephens D; West L; Wasfy S; Nelson S Clin Infect Dis; 2001 Jul; 33(2):145-50. PubMed ID: 11418872 [TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants. Meijer E; Dekker AW; Weersink AJ; Rozenberg-Arska M; Verdonck LF Br J Haematol; 2002 Dec; 119(3):596-607. PubMed ID: 12437632 [No Abstract] [Full Text] [Related]
12. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Lim WH; Russ GR; Coates PT Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577 [TBL] [Abstract][Full Text] [Related]
13. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants]. Hidalgo M; Lumbreras C; Aguado JM Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496 [No Abstract] [Full Text] [Related]
14. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load. Hoshino Y; Kimura H; Kuzushima K; Tsurumi T; Nemoto K; Kikuta A; Nishiyama Y; Kojima S; Matsuyama T; Morishima T Bone Marrow Transplant; 2000 Jul; 26(2):199-201. PubMed ID: 10918431 [TBL] [Abstract][Full Text] [Related]
15. [Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases]. Kuzushima K Rinsho Ketsueki; 2000 Jun; 41(6):487-90. PubMed ID: 10921347 [No Abstract] [Full Text] [Related]
16. Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation 2001; 72: 1399. Khanna A Transplantation; 2001 Oct; 72(8):1352-3. PubMed ID: 11685102 [No Abstract] [Full Text] [Related]
17. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468 [TBL] [Abstract][Full Text] [Related]
18. EBV specific CTL: a model for immune therapy. Rooney CM; Heslop HE; Brenner MK Vox Sang; 1998; 74 Suppl 2():497-8. PubMed ID: 9704488 [TBL] [Abstract][Full Text] [Related]